PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Sekar, R. ; Motzler, K. ; Kwon, Y. ; Novikoff, A. ; Jülg, J.* ; Najafi, B. ; Wang, S. ; Seitz, S. ; Hass, D, ; Gancheva, S.* ; Kahl, S.* ; Yang, B.* ; Finan, B.* ; Schwarz, K.* ; Okun, J.G.* ; Roden, M.* ; Blüher, M. ; Müller, T.D. ; Krahmer, N. ; Behrends, C.* ; Plettenburg, O. ; Miaczynska, M.* ; Herzig, S. ; Zeigerer, A.

Vps37a regulates hepatic glucose production by controlling glucagon receptor localization to endosomes.

Cell Metab. 34, 1824-1842.e9 (2022)
Verlagsversion Forschungsdaten Forschungsdaten DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
During mammalian energy homeostasis, the glucagon receptor (Gcgr) plays a key role in regulating both glucose and lipid metabolisms. However, the mechanisms by which these distinct signaling arms are differentially regulated remain poorly understood. Using a Cy5-glucagon agonist, we show that the endosomal protein Vps37a uncouples glucose production from lipid usage downstream of Gcgr signaling by altering intracellular receptor localization. Hepatocyte-specific knockdown of Vps37a causes an accumulation of Gcgr in endosomes, resulting in overactivation of the cAMP/PKA/p-Creb signaling pathway to gluconeogenesis without affecting β-oxidation. Shifting the receptor back to the plasma membrane rescues the differential signaling and highlights the importance of the spatiotemporal localization of Gcgr for its metabolic effects. Importantly, since Vps37a knockdown in animals fed with a high-fat diet leads to hyperglycemia, although its overexpression reduces blood glucose levels, these data reveal a contribution of endosomal signaling to metabolic diseases that could be exploited for treatments of type 2 diabetes.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
31.373
0.000
2
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Escrts ; Diabetes ; Endosomal Trafficking And Signaling ; Glucagon Receptor Biology And Signaling ; Liver Metabolism
Sprache englisch
Veröffentlichungsjahr 2022
HGF-Berichtsjahr 2022
ISSN (print) / ISBN 1550-4131
e-ISSN 1932-7420
Zeitschrift Cell Metabolism
Quellenangaben Band: 34, Heft: 11, Seiten: 1824-1842.e9 Artikelnummer: , Supplement: ,
Verlag Elsevier
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Cancer (IDC)
Institute of Diabetes and Obesity (IDO)
Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
Institute of Medicinal Chemistry (IMC)
POF Topic(s) 90000 - German Center for Diabetes Research
30201 - Metabolic Health
30203 - Molecular Targets and Therapies
Forschungsfeld(er) Helmholtz Diabetes Center
Enabling and Novel Technologies
PSP-Element(e) G-501900-254
G-502200-001
G-501900-251
G-506501-001
G-501900-221
G-506300-001
DOI 10.1016/j.cmet.2022.09.022
WOS ID WOS:000886558300003
Scopus ID 85140805138
PubMed ID 36243006
Erfassungsdatum 2022-10-25
[➜Korrektur melden]